Sfoglia per Autore
Vickers micro-hardness of new restorative CAD/CAM dental materials: Evaluation and comparison after exposure to acidic drink
2019-01-01 Colombo, M.; Poggio, C.; Lasagna, A.; Chiesa, M.; Scribante, A.
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center
2019-01-01 Garcia-Etienne, C. A.; Ferrari, A.; Della Valle, A.; Lucioni, M.; Ferraris, E.; Di Giulio, G.; Squillace, L.; Bonzano, E.; Lasagna, A.; Rizzo, G.; Tancredi, R.; Scotti Foglieni, A.; Dionigi, F.; Grasso, M.; Arbustini, E.; Cavenaghi, G.; Pedrazzoli, P.; Filippi, A. R.; Dionigi, P.; Sgarella, A.
The institution of a Multi-disciplinary Italian Breast Unit: Reflections of the first psychosocial research study results on distress and quality of life
2019-01-01 Dionigi, Francesca; Milani, R.; GARCIA ETIENNE, CARLOS ALBERTO; Pratico, V.; Riboni, G.; DELLA VALLE, Angelica; Ferrari, A.; Grasso, D.; Lasagna, Angioletta; Pedrazzoli, P.; Klersy, C.; Politi, P.; Sgarella, A.; Manna, S.; Conti, C.
How to use prophylactic G-CSF in the time of COVID-19
2020-01-01 Lasagna, A.; Zuccaro, V.; Ferraris, E.; Rizzo, G.; Tancredi, R. J.; Pedrazzoli, P.
G-CSF and G-CSF-related vasculitis: A systematic review of the literature and intriguing future research perspectives
2021-01-01 Muzzana, M.; Pedrazzoli, P.; Lasagna, A.
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study
2021-01-01 Lasagna, A.; Agustoni, F.; Percivalle, E.; Borgetto, S.; Paulet, A.; Comolli, G.; Sarasini, A.; Bergami, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Arena, F.; Lilleri, D.; Secondino, S.; Falzoni, M.; Schiavo, R.; Klersy, C.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
COVID-19 and breast cancer: May the microbiome be the issue?
2021-01-01 Lasagna, A.; Zuccaro, V.; Ferraris, E.; Corbella, M.; Bruno, R.; Pedrazzoli, P.
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?
2021-01-01 Lucioni, M.; Rossi, C.; Lomoro, P.; Ballati, F.; Fanizza, M.; Ferrari, A.; Garcia-Etienne, C. A.; Boveri, E.; Meloni, G.; Sommaruga, M. G.; Ferraris, E.; Lasagna, A.; Bonzano, E.; Paulli, M.; Sgarella, A.; Di Giulio, G.
Reply to Y. Ergun et al
2021-01-01 Lasagna, A.; Zuccaro, V.; Ferraris, E.; Corbella, M.; Bruno, R.; Pedrazzoli, P.
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study
2021-01-01 Di Cosimo, Serena; Tagliaferri, Barbara; Generali, Daniele; Giudici, Fabiola; Agustoni, Francesco; Bernardo, Antonio; Borgonovo, Karen; Farina, Gabriella; Luchena, Giovanna; Luciani, Andrea; Nolè, Franco; Palmeri, Laura; Pietrantonio, Filippo; Poggi, Guido; Zucali, Paolo Andrea; Balletti, Emanuela; Catania, Giovanna; Bernocchi, Ottavia; D'Antonio, Federica; Giordano, Monica; Grossi, Francesco; Lasagna, Angioletta; La Verde, Nicla; Manzoni, Mariangela; Montagna, Benedetta; Olgiati, Angelo; Raimondi, Alessandra; Rampinelli, Irene; Verri, Elena; Zaniboni, Alberto; Di Maio, Massimo; Beretta, Giordano; Danova, Marco
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research
2021-01-01 Lasagna, A.; Muzzana, M.; Pedrazzoli, P.
Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma
2021-01-01 Serra, F.; Faverio, C.; Lasagna, A.; Barruscotti, S.; Dominioni, T.; Benazzo, M.; Pedrazzoli, P.; Chiellino, S.
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study
2021-01-01 Lasagna, A; Agustoni, F; Percivalle, E; Borgetto, S; Paulet, A; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Lilleri, D; Secondino, S; Falzoni, M; Schiavo, R; Klersy, C; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I
Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons?
2021-01-01 Lasagna, Angioletta; Zuccaro, Valentina; Sacchi, Paolo; Chiellino, Silvia; Bruno, Raffaele; Pedrazzoli, Paolo
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
2022-01-01 Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Alessio, N.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM)
2022-01-01 Pedrazzoli, P; Lasagna, A; Cassaniti, I; Ferrari, A; Bergami, F; Silvestris, N; Sapuppo, E; Di Maio, M; Cinieri, S; Baldanti, F
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
2022-01-01 Lasagna, A.; Lilleri, D.; Agustoni, F.; Percivalle, E.; Borgetto, S.; Alessio, N.; Comolli, G.; Sarasini, A.; Bergami, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Arena, F.; Secondino, S.; Falzoni, M.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir
2022-01-01 Lasagna, Angioletta; Piralla, Antonio; Secondino, Simona; Sacchi, Paolo; Baldanti, Fausto; Bruno, Raffaele; Pedrazzoli, Paolo
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment
2022-01-01 Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I.
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment
2022-01-01 Lasagna, Angioletta; Cassaniti, Irene; Lilleri, Daniele; Quaccini, Mattia; Ferrari, Alessandra; Sacchi, Paolo; Bruno, Raffaele; Baldanti, Fausto; Pedrazzoli, Paolo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Vickers micro-hardness of new restorative CAD/CAM dental materials: Evaluation and comparison after exposure to acidic drink | 1-gen-2019 | Colombo, M.; Poggio, C.; Lasagna, A.; Chiesa, M.; Scribante, A. | |
| Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center | 1-gen-2019 | Garcia-Etienne, C. A.; Ferrari, A.; Della Valle, A.; Lucioni, M.; Ferraris, E.; Di Giulio, G.; Squillace, L.; Bonzano, E.; Lasagna, A.; Rizzo, G.; Tancredi, R.; Scotti Foglieni, A.; Dionigi, F.; Grasso, M.; Arbustini, E.; Cavenaghi, G.; Pedrazzoli, P.; Filippi, A. R.; Dionigi, P.; Sgarella, A. | |
| The institution of a Multi-disciplinary Italian Breast Unit: Reflections of the first psychosocial research study results on distress and quality of life | 1-gen-2019 | Dionigi, Francesca; Milani, R.; GARCIA ETIENNE, CARLOS ALBERTO; Pratico, V.; Riboni, G.; DELLA VALLE, Angelica; Ferrari, A.; Grasso, D.; Lasagna, Angioletta; Pedrazzoli, P.; Klersy, C.; Politi, P.; Sgarella, A.; Manna, S.; Conti, C. | |
| How to use prophylactic G-CSF in the time of COVID-19 | 1-gen-2020 | Lasagna, A.; Zuccaro, V.; Ferraris, E.; Rizzo, G.; Tancredi, R. J.; Pedrazzoli, P. | |
| G-CSF and G-CSF-related vasculitis: A systematic review of the literature and intriguing future research perspectives | 1-gen-2021 | Muzzana, M.; Pedrazzoli, P.; Lasagna, A. | |
| A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study | 1-gen-2021 | Lasagna, A.; Agustoni, F.; Percivalle, E.; Borgetto, S.; Paulet, A.; Comolli, G.; Sarasini, A.; Bergami, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Arena, F.; Lilleri, D.; Secondino, S.; Falzoni, M.; Schiavo, R.; Klersy, C.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I. | |
| COVID-19 and breast cancer: May the microbiome be the issue? | 1-gen-2021 | Lasagna, A.; Zuccaro, V.; Ferraris, E.; Corbella, M.; Bruno, R.; Pedrazzoli, P. | |
| Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? | 1-gen-2021 | Lucioni, M.; Rossi, C.; Lomoro, P.; Ballati, F.; Fanizza, M.; Ferrari, A.; Garcia-Etienne, C. A.; Boveri, E.; Meloni, G.; Sommaruga, M. G.; Ferraris, E.; Lasagna, A.; Bonzano, E.; Paulli, M.; Sgarella, A.; Di Giulio, G. | |
| Reply to Y. Ergun et al | 1-gen-2021 | Lasagna, A.; Zuccaro, V.; Ferraris, E.; Corbella, M.; Bruno, R.; Pedrazzoli, P. | |
| Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study | 1-gen-2021 | Di Cosimo, Serena; Tagliaferri, Barbara; Generali, Daniele; Giudici, Fabiola; Agustoni, Francesco; Bernardo, Antonio; Borgonovo, Karen; Farina, Gabriella; Luchena, Giovanna; Luciani, Andrea; Nolè, Franco; Palmeri, Laura; Pietrantonio, Filippo; Poggi, Guido; Zucali, Paolo Andrea; Balletti, Emanuela; Catania, Giovanna; Bernocchi, Ottavia; D'Antonio, Federica; Giordano, Monica; Grossi, Francesco; Lasagna, Angioletta; La Verde, Nicla; Manzoni, Mariangela; Montagna, Benedetta; Olgiati, Angelo; Raimondi, Alessandra; Rampinelli, Irene; Verri, Elena; Zaniboni, Alberto; Di Maio, Massimo; Beretta, Giordano; Danova, Marco | |
| Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research | 1-gen-2021 | Lasagna, A.; Muzzana, M.; Pedrazzoli, P. | |
| Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma | 1-gen-2021 | Serra, F.; Faverio, C.; Lasagna, A.; Barruscotti, S.; Dominioni, T.; Benazzo, M.; Pedrazzoli, P.; Chiellino, S. | |
| A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study | 1-gen-2021 | Lasagna, A; Agustoni, F; Percivalle, E; Borgetto, S; Paulet, A; Comolli, G; Sarasini, A; Bergami, F; Sammartino, J C; Ferrari, A; Zavaglio, F; Arena, F; Lilleri, D; Secondino, S; Falzoni, M; Schiavo, R; Klersy, C; Lo Cascio, G; Cavanna, L; Baldanti, F; Pedrazzoli, P; Cassaniti, I | |
| Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons? | 1-gen-2021 | Lasagna, Angioletta; Zuccaro, Valentina; Sacchi, Paolo; Chiellino, Silvia; Bruno, Raffaele; Pedrazzoli, Paolo | |
| Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study | 1-gen-2022 | Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Alessio, N.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Secondino, S.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I. | |
| Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) | 1-gen-2022 | Pedrazzoli, P; Lasagna, A; Cassaniti, I; Ferrari, A; Bergami, F; Silvestris, N; Sapuppo, E; Di Maio, M; Cinieri, S; Baldanti, F | |
| Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up | 1-gen-2022 | Lasagna, A.; Lilleri, D.; Agustoni, F.; Percivalle, E.; Borgetto, S.; Alessio, N.; Comolli, G.; Sarasini, A.; Bergami, F.; Sammartino, J. C.; Ferrari, A.; Zavaglio, F.; Arena, F.; Secondino, S.; Falzoni, M.; Schiavo, R.; Lo Cascio, G.; Cavanna, L.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I. | |
| Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir | 1-gen-2022 | Lasagna, Angioletta; Piralla, Antonio; Secondino, Simona; Sacchi, Paolo; Baldanti, Fausto; Bruno, Raffaele; Pedrazzoli, Paolo | |
| Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment | 1-gen-2022 | Lasagna, A.; Bergami, F.; Lilleri, D.; Percivalle, E.; Quaccini, M.; Comolli, G.; Sarasini, A.; Sammartino, J. C.; Ferrari, A.; Arena, F.; Cicognini, D.; Schiavo, R.; Lo Cascio, G.; Baldanti, F.; Pedrazzoli, P.; Cassaniti, I. | |
| Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment | 1-gen-2022 | Lasagna, Angioletta; Cassaniti, Irene; Lilleri, Daniele; Quaccini, Mattia; Ferrari, Alessandra; Sacchi, Paolo; Bruno, Raffaele; Baldanti, Fausto; Pedrazzoli, Paolo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile